HERTFORDSHIRE, England and PITTSBURGH, Dec. 17, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the Company will present at the J.P. Morgan 34th Annual Healthcare Conference on Tuesday, Jan. 12, 2016, in San Francisco. The presentation is scheduled to begin at 2:30 p.m. PST (5:30 p.m. EST).
Interested parties can access a live webcast of the presentation via the investor relations section of Mylan’s Web site at www.mylan.com/investors. An archived version will also be available following the live presentation and can be accessed at the same location for a limited time.
About Mylan
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what’s right, not what’s easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,400 generic and branded pharmaceuticals, including antiretroviral therapies on which nearly 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in approximately 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world’s largest producers of active pharmaceutical ingredients. Every member of our more than 30,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.
Logo - http://photos.prnewswire.com/prnh/20140423/77793
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-the-jp-morgan-34th-annual-healthcare-conference-300193902.html
SOURCE Mylan N.V.
